Amphion Innovations plc
Issue of Shares
London and New York, 24 March 2015- Amphion Innovations plc (LSE: AMP) (“Amphion” or the “Company”), the developer of medical and technology businesses, today announces that, further to the announcements on 5 June 2014 and 9 September 2014, the Company has issued 1,298,646 ordinary shares to YA Global Master SPV, Ltd. at a price of £0.0266 per ordinary share as a share-based interest payment, which is equal to 95% of the average of the 5 daily Volume Weighted Average Prices from 9 March to 19 March. The shares represent 0.85% of the enlarged issued share capital.
Admission of the 1,298,646 new ordinary shares, ranking pari passu with the existing ordinary shares, is expected 1 April 2015. Following this allotment the total issued share capital of the Company will increase to 152,069,866 ordinary shares with each share holding one voting right.
For further information please contact
+1 212 210 6224
Yellow Jersey PR
Dominic Barretto / Fiona Walker
+44 7768 537 739
Panmure Gordon Limited
Freddy Crossley / Fred Walsh (Corporate Finance)
Charlie Leigh-Pemberton (Corporate Broking)
+44 020 7886 2500
About Amphion Innovations plc
Amphion Innovations is a developer of medical, life science and technology businesses.
We use our extensive experience in company building to invest and build shareholder value in high growth companies in the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.
On the web: www.amphionplc.com